GRI Bio Future Growth
Future criteria checks 0/6
GRI Bio's earnings are forecast to decline at 4.5% per annum. EPS is expected to grow by 71.2% per annum.
Key information
-4.5%
Earnings growth rate
71.2%
EPS growth rate
| Biotechs earnings growth | 28.5% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 08 Oct 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | N/A | -9 | N/A | -7 | 1 |
| 12/31/2024 | N/A | -9 | N/A | -9 | 1 |
| 9/30/2024 | N/A | -8 | -12 | -12 | N/A |
| 6/30/2024 | N/A | -8 | -11 | -11 | N/A |
| 3/31/2024 | N/A | -13 | -11 | -11 | N/A |
| 12/31/2023 | N/A | -13 | -9 | -9 | N/A |
| 9/30/2023 | N/A | -13 | -4 | -4 | N/A |
| 6/30/2023 | N/A | -12 | -3 | -3 | N/A |
| 3/31/2023 | N/A | -5 | -2 | -2 | N/A |
| 12/31/2022 | N/A | -3 | -1 | -1 | N/A |
| 9/30/2022 | N/A | -1 | 0 | 0 | N/A |
| 12/31/2021 | N/A | -2 | -1 | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GRI is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: GRI is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: GRI is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: Insufficient data to determine if GRI's revenue is forecast to grow faster than the US market.
High Growth Revenue: GRI is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if GRI's Return on Equity is forecast to be high in 3 years time